Pharmaceutical

AbbVie’s Q2 2024 net earnings drop to $1.37bn

AbbVie has reported a 32.1% decrease in net earnings attributable to the company of $1.37bn in Q2 2024 from $2.02bn in Q2 last year.

Jul 28, 2024 - 04:00
AbbVie’s Q2 2024 net earnings drop to $1.37bn
AbbVie has reported a 32.1% decrease in net earnings attributable to the company of $1.37bn in Q2 2024 from $2.02bn in Q2 last year.
Read the original article

Tags:

Previous Article

Mankind Pharma acquires Bharat Serums and Vaccines for $1.6bn

Next Article

EC conditionally approves Pfizer’s haemophilia B gene therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

UK’s new Netflix-style funding model for antibiotics goes live

UK’s new Netflix-style funding model for antibiotics go...

Jun 16, 2024

STAT+: Key takeaways from AdvaMed, the world’s largest medical device conference

STAT+: Key takeaways from AdvaMed, the world’s largest ...

Oct 12, 2023

Datopotamab deruxtecan by Daiichi Sankyo for Peritoneal...

Apr 23, 2024